← FDA Drug Approvals (Drugs@FDA)
IMATINIB MESYLATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CSPC OUYI · Approved 2025-04-21
Drug application
- FDA Application #
ANDA212193- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- IMATINIB MESYLATE
- Generic name
- Imatinib Mesylate
- Active ingredients
- IMATINIB MESYLATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- CSPC OUYI
- First approval
- 2025-04-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown